caus
death
januari
china
infect
case
report
countri
howev
approv
drug
treat
diseas
pro
potenti
drug
target
combat
viru
built
homolog
model
base
sar
pro
structur
dock
small
molecul
drug
model
base
dock
score
similar
bind
mode
known
pro
ligand
drug
select
bind
free
energi
calcul
mmgbsa
sie
method
vote
nelfinavir
bind
free
energi
kcalmol
kcalmol
respect
therefor
suggest
nelfinavir
might
potenti
inhibitor
pro
authorfund
right
reserv
reus
allow
without
permiss
decemb
cluster
patient
pneumonia
report
wuhan
hubei
provinc
china
shortli
new
coronaviru
tempor
name
identifi
caus
diseas
seventh
member
famili
betacoronaviru
infect
case
death
report
januari
china
addit
infect
case
report
thailand
australia
malaysia
singapor
franc
japan
south
korea
unit
state
vietnam
canada
nepal
indic
diseas
potenti
threat
global
health
sadli
number
still
grow
rapidli
drug
approv
effect
therefor
urgent
discov
develop
drug
cure
diseas
base
function
main
proteas
pro
chymotrypsinlik
proteas
pro
suggest
potenti
drug
target
combat
highli
conserv
among
coronavirus
sequenc
align
reveal
pro
share
similar
sar
sever
acut
respiratori
syndrom
figur
studi
identifi
inhibitor
pro
quickli
perform
discov
develop
drug
diseas
exampl
hualiang
jiang
collabor
identifi
drug
compound
pro
inhibitor
via
protein
model
virtual
screen
rapid
progress
way
cope
crisi
addit
one
drugscompound
remdesivir
also
suggest
potenti
inhibitor
liu
et
al
find
potenti
drug
inhibitor
protein
model
pro
structur
use
sar
pro
pdb
id
templat
dock
approv
drug
model
studi
fifteen
drug
select
base
dock
score
three
dimension
similar
avail
pro
inhibitor
coronaviru
valid
model
addit
new
model
pro
dock
drug
new
model
reveal
drug
nelfinavir
praziquantel
pitavastatin
perampanel
eszopiclon
zopiclon
good
bind
mode
new
model
bind
free
energi
calcul
perform
drug
use
mmgbsa
sie
method
nelfinavir
identifi
best
one
predict
bind
free
energi
kcalmol
mmgbsa
kcalmol
sie
respect
take
account
high
similar
bind
mode
known
pro
inhibitor
propos
nelfinavir
potenti
inhibitor
pro
homolog
model
pro
complex
ligand
download
protein
data
bank
pdb
id
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
align
pymol
improv
score
minim
hydrogen
ad
pro
model
ffamber
ffoutamb
chain
model
convert
pdbqt
format
script
mgltoo
version
ligand
use
defin
grid
buffer
space
set
autoboxadd
random
seed
explicitli
set
seed
exhaust
global
search
set
exhaust
bind
mode
gener
drug
nummod
molshac
util
gaussianbas
descript
molecular
shape
charg
distribut
use
calcul
similar
approv
drug
avail
pro
inhibitor
molecular
dynam
simul
simul
system
immers
cubic
box
water
extend
solut
ration
number
counter
ion
na
clto
neutral
system
gener
amber
forc
field
gaff
amber
forc
field
use
parameter
ligand
protein
respect
step
minim
constraint
heavi
atom
complex
includ
step
steepest
descent
minim
step
conjug
gradient
minim
use
optim
system
system
heat
k
within
ns
follow
ns
equilibr
npt
ensembl
final
ns
md
simul
system
k
perform
minim
heat
equilibrium
perform
sander
program
ns
product
run
perform
pmemdcuda
base
ns
md
simul
trajectori
bind
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
free
energi
calcul
mmgbsa
sie
approach
mmgbsa
calcul
accord
equat
refer
electrostat
van
der
waal
energi
term
respect
refer
polar
nonpolar
solvat
free
energi
respect
conform
entropi
calcul
nmode
modul
dielectr
constant
solvent
solut
set
respect
obc
solvat
model
igb
pbradii
use
studi
paramet
set
default
valu
sie
calcul
base
equat
ec
evdw
refer
sum
intermolecular
coulomb
van
der
waal
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
visual
dock
complex
care
select
drug
tabl
analysi
differ
conform
protein
similar
refer
model
therefor
model
new
homolog
model
use
protein
similar
refer
templat
redock
drug
new
homolog
model
drug
nelfinavir
pitavastatin
perampanel
praziquantel
zopiclon
eszopiclon
show
good
dock
score
bind
mode
tabl
eszopiclon
zopiclon
use
treat
insomnia
low
dosag
may
suitabl
treat
pneumonia
carri
bind
free
energi
calcul
rest
drug
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
subject
ns
molecular
dynam
simul
use
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
amber
provid
insight
bind
mechan
bind
free
energi
calcul
mmgbsa
sie
approach
result
mmgbsa
approach
calcul
bind
free
energi
kcalmol
respect
tabl
highlight
nelfinavir
activ
one
van
der
waal
interact
e
vdw
make
signific
contribut
electrostat
interact
e
ele
shown
figur
bind
model
nelfinavir
dock
complex
turn
similar
origin
ligand
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
caus
death
china
januari
potenti
threat
global
health
howev
approv
drug
treat
diseas
pro
potenti
drug
target
combat
viru
share
sequenc
similar
correspond
one
sar
built
homolog
model
pro
dock
approv
small
molecul
drug
model
base
dock
score
similar
bind
mode
known
pro
binder
drug
select
evalu
drug
dock
homolog
model
lead
drug
bind
energi
calcul
mmgbsa
sie
calcul
vote
nelfinavir
proteas
inhibitor
treat
hiv
therefor
suggest
nelfinavir
might
activ
pro
addit
pitavastatin
perampanel
praziquantel
might
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
also
moder
activ
